Glenmark Pharmaceuticals Reports Massive Q4 Profit Surge Amid Market Volatility
Glenmark Pharmaceuticals Ltd. announced a dramatic financial turnaround on May 30, reporting a consolidated net profit of ₹301.4 crore for the fourth quarter ending March 2026. This performance represents a staggering 6,400% increase compared to the ₹4.6 crore profit recorded during the same period in the previous fiscal year. Despite the robust bottom-line growth, the…